|
METT10D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.339190E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.302100E-03 |
| Normal-vs-Stage2 |
4.195900E-02 |
| Normal-vs-Stage3 |
5.235900E-04 |
| Normal-vs-Stage4 |
3.754400E-04 |
| Stage1-vs-Stage2 |
8.030000E-01 |
| Stage1-vs-Stage3 |
4.370600E-01 |
| Stage1-vs-Stage4 |
1.787390E-01 |
| Stage2-vs-Stage3 |
4.257200E-01 |
| Stage2-vs-Stage4 |
1.747010E-01 |
| Stage3-vs-Stage4 |
3.593400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.351500E-04 |
| Normal-vs-AfricanAmerican |
7.953200E-01 |
| Normal-vs-Asian |
1.094220E-01 |
| Caucasian-vs-AfricanAmerican |
5.398400E-03 |
| Caucasian-vs-Asian |
2.120000E-01 |
| AfricanAmerican-vs-Asian |
1.432590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.863600E-03 |
| Normal-vs-Female |
1.980070E-03 |
| Male-vs-Female |
9.539600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.552100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.223500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.574400E-04 |
| Normal-vs-Age(81-100Yrs) |
4.856600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.931200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.180250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.125210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.949400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.956620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.405400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.158660E-04 |
| Classical-VS-Follicular |
7.248300E-04 |
| Classical-VS-Other |
2.886200E-01 |
| Classical-VS-Normal |
4.487800E-02 |
| Tall-VS-Follicular |
4.734800E-01 |
| Tall-VS-Other |
7.362800E-01 |
| Tall-VS-Normal |
4.02369999996655E-06 |
| Follicular-VS-Other |
9.508600E-01 |
| Follicular-VS-Normal |
4.46699999999689E-05 |
| Other-VS-Normal |
6.709700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.772000E-04 |
| Normal-vs-N1 |
1.243330E-03 |
| N0-vs-N1 |
3.721200E-01 |
|
|
